FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harald Mohr

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Phenomena

Procedures

Concepts & Ideas

Time Factors

Physiology

Virus Replication

Co-author Network

Publications

TOP 3
Harald Mohr; Leif Steil; Ute Gravemann; Thomas Thiele; Elke Hammer; Andreas Greinacher; Thomas H Müller; Uwe Völker
A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light.
Harald Mohr; Ute Gravemann; Thomas H Müller
Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light.
Harald Mohr; Ute Gravemann; Anette Bayer; Thomas H Müller
Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harald Mohr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Harald Mohr; Leif Steil; Ute Gravemann; Thomas Thiele; Elke Hammer; Andreas Greinacher; Thomas H Müller; Uwe Völker
A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light.
Transfusion 2009;49(12):2612-24.
2009: Harald Mohr; Ute Gravemann; Thomas H Müller
Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light.
Transfusion 2009;49(10):2144-51.
2009: Harald Mohr; Ute Gravemann; Anette Bayer; Thomas H Müller
Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.
Transfusion 2009;49(9):1956-63.
2006: Harald Mohr; Anette Bayer; Ute Gravemann; Thomas H Müller
Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates.
Transfusion 2006;46(6):949-55.
2006: Harald Mohr; Bernd Lambrecht; Anette Bayer; Hans-Peter Spengler; Sven-Boris Nicol; Thomas Montag; Thomas H Müller
Sterility testing of platelet concentrates prepared from deliberately infected blood donations.
Transfusion 2006;46(3):486-91.
2006: Harald Mohr; Bernd Lambrecht; Anette Bayer; Hans-Peter Spengler; Sven-Boris Nicol; Thomas Montag; Thomas H Müller
Basics of flow cytometry-based sterility testing of platelet concentrates.
Transfusion 2006;46(1):41-9.
2004: Harald Mohr; Joseph Knüver-Hopf; Ute Gravemann; Anette Redecker-Klein; Thomas H Müller
West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
Transfusion 2004;44(6):886-90.
2003: Harald Mohr; A Redecker-Klein
Inactivation of pathogens in platelet concentrates by using a two-step procedure.
Vox sanguinis 2003;84(2):96-104.
2001: Harald Mohr
Methylene blue and thionine in pathogen inactivation of plasma and platelet concentrates.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2001;25(3):183-4.
1998: K Müller-Breitkreutz; Harald Mohr
Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma.
Journal of medical virology 1998;56(3):239-45.
1997: Harald Mohr; B Bachmann; A Klein-Struckmeier; Bernd Lambrecht
Virus inactivation of blood products by phenothiazine dyes and light.
Photochemistry and photobiology 1997;65(3):441-5.
1997: A Klein-Struckmeier; Harald Mohr
Photodynamic virus inactivation of thrombocyte concentrates by phenothiazine dyes.
Beiträge zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine 1997;34():43-7.
1997: K Müller-Breitkreutz; Harald Mohr
Infection cycle of herpes viruses after photodynamic treatment with methylene blue and light.
Beiträge zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine 1997;34():37-42.
1995: J Knüver-Hopf; Harald Mohr
Differences between natural and recombinant interleukin-2 revealed by gel electrophoresis and capillary electrophoresis.
Journal of chromatography. A 1995;717(1-2):71-4.
1995: B Bachmann; J Knüver-Hopf; B Lambrecht; Harald Mohr
Target structures for HIV-1 inactivation by methylene blue and light.
Journal of medical virology 1995;47(2):172-8.
1995: K Müller-Breitkreutz; Harald Mohr; K Briviba; H Sies
Inactivation of viruses by chemically and photochemically generated singlet molecular oxygen.
Journal of photochemistry and photobiology. B, Biology 1995;30(1):63-70.
1995: Harald Mohr; B Lambrecht; A Selz
Photodynamic virus inactivation of blood components.
Immunological investigations 1995;24(1-2):73-85.
1994: B Lambrecht; S G Norley; R Kurth; Harald Mohr
Rapid inactivation of HIV-1 in single donor preparations of human fresh frozen plasma by methylene blue/light treatment.
Biologicals : journal of the International Association of Biological Standardization 1994;22(3):227-31.
1994: Harald Mohr; B Lambrecht; F Marks; A Tschech
Hepatitis A virus PCR analysis of clotting factor concentrates and elimination of non-enveloped viruses in their manufacture.
Vox sanguinis 1994;67 Suppl 1():78-9.
1993: Harald Mohr; U Pohl; B Lambrecht; J U Wieding; H Schmitt
[Methylene blue/light treatment of virus inactivated human plasma: production and clinical experience].
Infusionstherapie und Transfusionsmedizin 1993;20 Suppl 2():19-24.
1993: J Knüver-Hopf; H Heinze; B Lambrecht; Harald Mohr; J Beyer; H Schmitt
Blood donations indeterminate in HIV-1 western blot analysed by IgM immunoblot and polymerase chain reaction.
Vox sanguinis 1993;64(2):89-93.
1993: Harald Mohr; B Lambrecht; H Schmitt
Photo-inactivation of viruses in therapeutical plasma.
Developments in biological standardization 1993;81():177-83.
1993: Harald Mohr; B Lambrecht; H Schmitt
[Optimizing parameters in photodynamic virus inactivation of fresh frozen plasma].
Beiträge zur Infusionstherapie = Contributions to infusion therapy 1993;31():25-30.
1992: Harald Mohr; J Knüver-Hopf; B Lambrecht; H Scheidecker; H Schmitt
No evidence for neoantigens in human plasma after photochemical virus inactivation.
Annals of hematology 1992;65(5):224-8.
1992: Harald Mohr; B Lambrecht; J Knuever-Hopf
Virus inactivated single-donor fresh plasma preparations.
Infusionstherapie und Transfusionsmedizin 1992;19(2):79-83.
1991: Holger Kirchner; A Körfer; P Evers; M M Szamel; J Knüver-Hopf; Harald Mohr; C R Franks; U Pohl; K Resch; M Hadam
The development of neutralizing antibodies in a patient receiving subcutaneous recombinant and natural interleukin-2.
Cancer 1991;67(7):1862-4.
1991: A Klein-Struckmeier; J Knüver-Hopf; Harald Mohr
Modulation of natural and interleukin-2-induced tumour-cytolytic activities by the members of a protein family related to beta-thromboglobulin.
Cancer immunology, immunotherapy : CII 1991;34(3):175-80.
1991: H Schmitt; Harald Mohr; B Lambrecht; J Knüver-Hopf
[Virus inactivation of plasma].
Beiträge zur Infusionstherapie = Contributions to infusion therapy 1991;28():82-91.
1991: B Lambrecht; Harald Mohr; J Knüver-Hopf; H Schmitt
Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.
Vox sanguinis 1991;60(4):207-13.
1990: Jens Atzpodien; A Körfer; P Evers; C R Franks; J Knüver-Hopf; E Lopez-Hänninen; M Fischer; Harald Mohr; Iris Dallmann; M Hadam
Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study.
Molecular biotherapy 1990;2(1):18-26.
1989: T Volgmann; A Klein-Struckmeier; Harald Mohr
A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity.
Journal of immunological methods 1989;119(1):45-51.
1989: J Knüver-Hopf; Harald Mohr; J Beyer; B Lambrecht; D Mix; H Rübsamen-Waigmann; H Schmitt
HIV-2 antibody testing of blood donors with doubtful immunoblot results for HIV-1.
Blut 1989;58(3):155-7.
1988: Mathias Freund; P von Wussow; J Knüver-Hopf; Harald Mohr; U Pohl; G Exeriede; H Link; H J Wilke; H Poliwoda
Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.
Blut 1988;57(5):311-5.
1987: Harald Mohr; George R Pettit; A Plessing-Menze
Co-induction of lymphokine synthesis by the antineoplastic bryostatins.
Immunobiology 1987;175(5):420-30.
1987: J Knüver-Hopf; Harald Mohr; G Caspari; J Beyer; H Schmitt
Re.: Colour stability of new anti-HIV immunogold blotting versus conventional immunoblotting techniques.
Journal of immunological methods 1987;100(1-2):281-2.
1987: J Knüver-Hopf; Harald Mohr
[A gold immunoblot assay for the determination of antibodies against HIV].
Beiträge zu Infusionstherapie und klinische Ernährung 1987;18():37-8.
1987: A Stecher; Harald Mohr; K Schügerl
[Lymphokine production using IL-2-dependent human T-lymphocytes].
Beiträge zu Infusionstherapie und klinische Ernährung 1987;18():292-4.
1987: H Benedikter; Harald Mohr
[Virus inactivation in the preparation of plasma proteins].
Beiträge zu Infusionstherapie und klinische Ernährung 1987;18():25-9.
1987: J Knüver-Hopf; Harald Mohr
[Use of 2D IEF/SDS-PAGE and immunoblotting for the analysis of a factor VIII concentrate].
Beiträge zu Infusionstherapie und klinische Ernährung 1987;18():186-8.
1984: A Stecher; Harald Mohr; K Schügerl
Interferon-alpha yields from Sendai virus-induced human leukocyte cultures are enhanced by lowering the incubation temperature.
The Journal of general virology 1984;65 ( Pt 3)():635-8.